Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keefer

Showing results (1041-1050 of 1,129) with videos related to

Pageof 113
Sort By:
Msphere|January 31, 2020
Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV InfectionZanele Ditse, Nonhlanhla N Mkhize, Michael Yin, et al.
The Journal of Infectious Diseases|November 26, 2009
Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimensDavid M Asmuth, Elizabeth L Brown, Mark J DiNubile, et al.
Nature|August 22, 2008
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivorsXiaocong Yu, Tshidi Tsibane, Patricia A McGraw, et al.
Journal of Vascular Surgery|January 8, 2008
Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasiaMuneera R Kapadia, Lesley W Chow, Nick D Tsihlis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
Time to Viral Rebound After Interruption of Modern Antiretroviral TherapiesJonathan Z Li, Evgenia Aga, Ronald J Bosch, et al.
Plos One|November 15, 2018
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1Kathryn E Stephenson, Michael C Keefer, Catherine A Bunce, et al.
Cell Reports. Medicine|September 25, 2024
Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIVTimothy J Henrich, Ronald J Bosch, Catherine Godfrey, et al.
Journal of Medicinal Chemistry|September 19, 2009
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasisGanesha Rai, Ahmed A Sayed, Wendy A Lea, et al.
Clinical Transplantation|October 27, 1998
Reducing the length of stay after kidney transplantation--the intensive outpatient unitR Shapiro, M L Jordan, V P Scantlebury, et al.
The Journal of Infectious Diseases|June 5, 2020
Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral TherapyNikolaus Jilg, Pilar Garcia-Broncano, Michael Peluso, et al.
Pageof 113

Showing results (1041-1050 of 1,129) with videos related to

Sort By:
Pageof 113
Msphere|January 31, 2020
Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV InfectionZanele Ditse, Nonhlanhla N Mkhize, Michael Yin, et al.
The Journal of Infectious Diseases|November 26, 2009
Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimensDavid M Asmuth, Elizabeth L Brown, Mark J DiNubile, et al.
Nature|August 22, 2008
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivorsXiaocong Yu, Tshidi Tsibane, Patricia A McGraw, et al.
Journal of Vascular Surgery|January 8, 2008
Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasiaMuneera R Kapadia, Lesley W Chow, Nick D Tsihlis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
Time to Viral Rebound After Interruption of Modern Antiretroviral TherapiesJonathan Z Li, Evgenia Aga, Ronald J Bosch, et al.
Plos One|November 15, 2018
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1Kathryn E Stephenson, Michael C Keefer, Catherine A Bunce, et al.
Cell Reports. Medicine|September 25, 2024
Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIVTimothy J Henrich, Ronald J Bosch, Catherine Godfrey, et al.
Journal of Medicinal Chemistry|September 19, 2009
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasisGanesha Rai, Ahmed A Sayed, Wendy A Lea, et al.
Clinical Transplantation|October 27, 1998
Reducing the length of stay after kidney transplantation--the intensive outpatient unitR Shapiro, M L Jordan, V P Scantlebury, et al.
The Journal of Infectious Diseases|June 5, 2020
Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral TherapyNikolaus Jilg, Pilar Garcia-Broncano, Michael Peluso, et al.
Pageof 113